Drug Profile
Research programme: micrin-related therapeutics - Endocrine Pharmaceuticals
Alternative Names: EPL 001Latest Information Update: 28 Sep 2020
Price :
$50
*
At a glance
- Originator Endocrine Pharmaceuticals
- Class Antineoplastics; Gonadal hormones
- Mechanism of Action Apoptosis stimulants; Gonadal hormone modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 28 Sep 2020 No recent reports of development identified for preclinical development in Cancer in United Kingdom
- 02 Aug 2016 Micrin related therapeutics are available for licensing as of 2 Aug 2016. https://www.endopharm.co.uk/strategy
- 02 Aug 2016 Preclinical trials in Cancer in United Kingdom (unspecified route)